Klinikum St. Georg gGmbH — Clinical Trial Site

19 Registered trials

10 Currently recruiting

Organisation

Klinikum St. Georg gGmbH

Location

Leipzig, Germany

Identifier

ORG-100020655

Address

Delitzscher Strasse 141, Eutritzsch, 04129, Germany

Departments

Clinic for Gastroenterology, Hepatology, Diabetology and Endocrinology
D10-513: Nephrology
Gynäkologie und Geburtshilfe
IDCL (ImmunodeficiencyCenter Leipzig)
Infectious diseases
Internist. Onkologie/Hämatologie
Klinik für Allgemein-, Viszeral-, Thorax- und Gefäßchirurgie
Klinik für Anästhesiologie, Intensiv- und Schmerztherapie
Klinik für Gastroenterologie, Hepatologie, Diabetologie und Endokrinologie
Klinik für Gynäkologie und Geburtshilfe
Klinik für Infektiologie und Tropenmedizin
Klinik für Kinder- und Jugendmedizin
Klinik für Nephrologie
Klinik für Strahlentherapie und Radioonkologie
Klinikum St. Georg - Gynäkologie und Geburtshilfe
Onkologie und Hämatologie
paediatric rheumatology
Pediatric Rheumatology

Clinical trials at this site (19)

Search interface

Efficacy and safety of Dalbavancin in the treatment of infective Endocarditis caused by gram-positive cocci Pending

2026-526149-91-00 Infectious endocarditis caused by Gram-positive cocci ( 5
Safety, tolerability, pharmacokinetics, and efficacy of filgotinib for the treatment of polyarticular-course juvenile idiopathic arthritis i… Recruiting

2024-511593-70-00 Polyarticular-course juvenile idiopathic arthritis 5 2026-04-27
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN). Recruiting

2024-514135-17-00 Immunoglobulin A Nephropathy 5 2024-11-28
Ulcerative Colitis: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects with Moderately to Severely Active Ulcerati… Recruiting

2022-501788-41-00 Ulcerative Colitis 5 2023-11-14
Open-label extension study with filgotinib in children with juvenile idiopathic arthritis. Recruiting

2025-523239-21-00 Juvenile idiopathic arthritis 5 2026-04-13
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Subjects With Primary Membranous Nephropathy Recruiting

2025-521661-27-00 Primary Membranous Nephropathy 10 2025-12-19
Pre-Operative Treatment in rEseCTable cOlon canceR (PROTECTOR/FIRE-10; AIO-KRK-0620; IAG-VO-0323) Prospective, randomized, open-label, multi… Recruiting

2023-508076-11-00 Colon cancer staged T3-4 and/or nodal positive by CT an 5 2025-04-01
Role of Pancreatic Enzyme Replacement Therapy (PERT) (Creon®) for Pancreatic Exocrine Insufficiency (PEI) after Pancreatic Surgery Recruiting

2024-512798-29-00 Male and female patients aged ≥ 18 to ≤ 85 years with a 5 2025-01-07
Staphylococcus aureus Network Adaptive Platform trial (SNAP) Recruiting

2023-503582-35-00 Staphylococcus aureus bacteremia 6 2023-10-26
The Pancreatic Enzymes after Gastrectomy Trial Recruiting

2022-501944-14-00 Patients after gastrectomy (total and partial) 5 2023-10-02
Cholangiocarcinoma treatment with radiofrequency ablation or photodynamic therapy Recruiting

2022-500107-50-00 hilar cholangiocarcinoma 6 2022-10-12
Combination of Abemaciclib and endocrine therapy in hormone receptor positive HER2 negative locally advanced or metastatic breast cancer wit… Ended

2024-511209-49-00 Patients with hormone receptor positive HER2 negative l 6 2022-04-26
A randomized, controlled, open-label, phase III-trial on Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing abemaciclib combi… Ended

2023-509242-35-00 HR+/HER2- early breast cancer 5 2020-07-23
Short course radiotherapy versus chemoradiotherapy, followed by consolidation chemotherapy, and selective organ preservation for MRI-defined… Ended

2024-511577-29-01 intermediate and high-risk rectal cancer 5 2020-03-13
Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate-risk… Ended

2024-515769-32-00 HR+/HER2- early breast cancer 5 2019-07-02
VItamin C in Thermal injuRY: The VICToRY Trial A phase III multi-center randomized trial Ended

2023-504772-21-00 Severely burned patients 4 2022-11-22
Zibotentan and Dapagliflozin combination, Evaluated in Liver cirrhosis (ZEAL study) Ended

2023-505405-17-00 Liver cirrhosis with features of portal hypertension. 4 2022-10-07
Prospective, open-label, single-arm, multicentre Phase 3 study to evaluate the pharmacokinetics, efficacy, tolerability, and safety of subcu… Ended

2024-511231-94-00 Human Normal Immunoglobulin 5 2021-10-27
CIRCULATE Ended

2023-506715-18-00 colon cancer stage II, rectal cancer stage II 5 2019-12-04